Temozolomide capsule Clinical Trials

4 actively recruiting trials

Also known as: Temodal

Pipeline

Phase 2: 3Phase 1/2: 1

Top Sponsors

Tianjin Medical University Second Hospital1
Institute of Cancer Research, United Kingdom1
European Institute of Oncology1
Asan Medical Center1

Indications

Cancer4
Malignant Primary Gliomas1
Precision Medicine1
Glioblastoma Multiforme (GBM)1
Gastrointestinal Stromal Tumors1

Other4 trials

5G-PEARL: Paxalisib in Malignant Brain Tumours

Phase 1/2

Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe Study

Phase 2

Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion

Phase 2

The Efficacy and Safety of Temozolomide in SDH-deficient GIST

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.